Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Armata Pharmaceuticals (ARMP) Liabilities and Shareholders Equity: 2013-2017

Historic Liabilities and Shareholders Equity for Armata Pharmaceuticals (ARMP) over the last 5 years, with Dec 2017 value amounting to $11.1 million.

  • Armata Pharmaceuticals' Liabilities and Shareholders Equity fell 22.94% to $10.6 million in Q3 2018 from the same period last year, while for Sep 2018 it was $47.9 million, marking a year-over-year decrease of 21.95%. This contributed to the annual value of $11.1 million for FY2017, which is 38.64% down from last year.
  • Armata Pharmaceuticals' Liabilities and Shareholders Equity amounted to $11.1 million in FY2017, which was down 38.64% from $18.2 million recorded in FY2016.
  • In the past 5 years, Armata Pharmaceuticals' Liabilities and Shareholders Equity registered a high of $41.2 million during FY2013, and its lowest value of $11.1 million during FY2017.
  • For the 3-year period, Armata Pharmaceuticals' Liabilities and Shareholders Equity averaged around $20.3 million, with its median value being $18.2 million (2016).
  • Per our database at Business Quant, Armata Pharmaceuticals' Liabilities and Shareholders Equity rose by 10.05% in 2015 and then slumped by 42.36% in 2016.
  • Armata Pharmaceuticals' Liabilities and Shareholders Equity (Yearly) stood at $41.2 million in 2013, then tumbled by 30.56% to $28.6 million in 2014, then increased by 10.05% to $31.5 million in 2015, then tumbled by 42.36% to $18.2 million in 2016, then slumped by 38.64% to $11.1 million in 2017.